Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid

Paediatrics and Child Health (Canada)

Volumn 17, Issue 5, 2012, Pages

  Smith, Ryan W ^a   Downey, Kim ^b   Gordon, Michelle ^b,c,d   Hudak, Alan ^b,d   Meeder, Rob ^b,e   Barker, Sarah ^b   Smith, W Gary ^b,c,d,e  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Orillia Soldiers' Memorial Hospital   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^e WESTERN UNIVERSITY   (Canada)

Author keywords

Asthma; Hypothalamic pituitary adrenal axis; Inhaled corticosteroid

Indexed keywords

BECLOMETASONE; CICLESONIDE; FLUTICASONE; HYDROCORTISONE; SALMETEROL;

ADRENAL SUPPRESSION; ARTICLE; ASTHMA; CHILD; CORTICOTROPIN TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS PITUITARY ADRENAL AXIS SUPPRESSION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD;

EID: 84861634683     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/17.5.e34     Document Type: Article

References (30)

1. Global strategy for asthma management and prevention, global initiative for asthma (GINA). 2008. 〈www.ginasthma.org/guidelines-gina-report-global- strategy-for-asthma.html〉 (Accessed November 5, 2011).
2. Becker A, Lemiere C, Berube D, et al. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ 2005;173(6 Suppl):S3-11.
3. Bethesda MNH, Lung, and Blood Institute. Program: Expert panel report III: Guidelines for the diagnosis and management of asthma 2007. 〈www.ncbi.nlm.nih.gov/books/NBK7232/〉 (Accessed November 5, 2011).
4. Lougheed MD, Lemiere C, Dell SD, et al. Canadian Thoracic Society Asthma Management Continuum - 2010 Consensus Summary for children six years of age and over, and adults. Can Respir J 2010;17:15-24.
5. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998;157(3 Pt 2):S1-53.
6. Geddes DM. Inhaled corticosteroids: Benefits and risks. Thorax 1992;47:404-7.
7. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999;159:941-55. (Pubitemid 29222495)
8. Barnes NC. The properties of inhaled corticosteroids: Similarities and differences. Prim Care Respir J 2007;16:149-54. (Pubitemid 46890606)
9. Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 2003;5:481-504. (Pubitemid 36976118)
10. Mellis CM, Phelan PD. Asthma deaths in children - a continuing problem. Thorax Feb 1977;32:29-34. (Pubitemid 8023992)
11. Zollner EW. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: Part 1. Which test should be used? Pediatr Allergy Immunol 2007;18:401-9. (Pubitemid 47039145)
12. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002;87:457-61. (Pubitemid 35440691)
13. Pedersen S. Clinical safety of inhaled corticosteroids for asthma in children: An update of long-term trials. Drug Saf 2006;29:599-612. (Pubitemid 44175030)
14. Ahmet A, Kim H, Spier S. Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol 2011;7:13.
15. Zollner EW, Lombard C, Galal U, Hough S, Irusen E, Weinberg E. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids - more common than expected? J Pediatr Endocrinol Metab 2011;24:529-34.
16. Zollner EW. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2) - the risk as determined by gold standard adrenal function tests: A systematic review. Pediatr Allergy Immunol 2007;18:469-74. (Pubitemid 47206740)
17. Smith RW, Landry B, Downey K, Smith WG. Retrospective analysis of prescribing trends in asthma care. 87th Canadian Pediatric Society Annual Conference. Vancouver, British Columbia 2010. (Abst)
18. Ahmet A. Standard Testing Protocol Children's Hospital of Eastern Ontario ACTH for asthma patients. [correspondence WG Smith 2010].
19. Altman DG. Practical statistics for medical research. New York, NY: Chapman and Hall; 1991.
20. Public Health Agency of Canada. Life and breath: Respiratory disease in Canada. 2007. 〈www.phac-aspc.gc.ca/publicat/2007/lbrdc-vsmrc/asthma-asthme- eng.php〉 (Accessed November 5, 2011).
21. Shah A, Stanhope R, Matthew D. Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 1992;304:173-4.
22. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994;79:923-31.
23. Priftis KN, Papadimitriou A, Nicolaidou P, Chrousos GP. Testing for hypothalamic-pituitary-adrenal axis suppression in asthmatic children. Pediatr Allergy Immunol 2008;19(5):466-67; author reply 468-70.
24. Zollner EW, Lombard C, Galal U, Hough S, Irusen E, Weinberg E. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: Is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test? Pediatr Allergy Immunol 2011;22:614-20.
25. Wade M, Baid S, Calis K, Raff H, Sinaii N, Nieman L. Technical details influence the diagnostic accuracy of the 1 μg ACTH stimulation test. Eur J Endocrinology 2010;162:109-13.
26. British Thoracic Society SIGN. British Guideline on the Management of Asthma 〈www.sign.ac.uk/guidelines/fulltext/101/index.html〉 (Accessed November 5, 2011).
27. Todd G, Acerini CL, Buck JJ, et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Resp J 2002;19:1207-9. (Pubitemid 34649639)
28. Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC. Lesson of the week: Symptomatic adrenal insufficiency presenting with hypoglycaemia in asthmatic children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002;324:1081-2. (Pubitemid 34492819)
29. Heller MK, Laks J, Kovesi TA, Ahmet A. Reversal of adrenal suppression with ciclesonide. J Asthma 2010;47:337-9.
30. Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW. Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab 1965;25:11-16.